Jonathan S. Leff, Director at ZYMOGENETICS INC (ZGEN), bought 98,254 shares at $9.20 ($917K) on 2008-03-05, disclosed to the SEC on 2008-03-07.
Open-market purchase of $917k ZGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.17 | 200 | $2K | 0.2% |
| 2 | $9.18 | 1,600 | $15K | 1.6% |
| 3 | $9.19 | 2,300 | $21K | 2.3% |
| 4 | $9.20 | 4,400 | $40K | 4.4% |
| 5 | $9.21 | 2,900 | $27K | 2.9% |
| 6 | $9.22 | 3,500 |
| $32K |
| 3.5% |
| 7 | $9.23 | 2,533 | $23K | 2.5% |
| 8 | $9.24 | 5,400 | $50K | 5.4% |
| 9 | $9.25 | 7,367 | $68K | 7.4% |
| 10 | $9.26 | 2,500 | $23K | 2.5% |
| 11 | $9.28 | 1,300 | $12K | 1.3% |
| 12 | $9.29 | 100 | $929 | 0.1% |
| 13 | $9.30 | 1,100 | $10K | 1.1% |
| 14 | $9.31 | 1,100 | $10K | 1.1% |
| 15 | $9.32 | 4,400 | $41K | 4.5% |
| 16 | $9.33 | 1,700 | $16K | 1.7% |
| 17 | $9.34 | 2,895 | $27K | 2.9% |
| 18 | $9.35 | 400 | $4K | 0.4% |
| 19 | $9.36 | 1,200 | $11K | 1.2% |
| 20 | $9.37 | 3,359 | $31K | 3.4% |
| 21 | $9.38 | 2,100 | $20K | 2.1% |
| 22 | $9.39 | 6,800 | $64K | 7.0% |
| 23 | $9.40 | 19,300 | $181K | 19.8% |
| 24 | $9.41 | 4,100 | $39K | 4.2% |
| 25 | $9.42 | 3,800 | $36K | 3.9% |
| 26 | $9.43 | 4,900 | $46K | 5.0% |
| 27 | $9.44 | 5,100 | $48K | 5.2% |
| 28 | $9.45 | 200 | $2K | 0.2% |
| 29 | $9.46 | 1,600 | $15K | 1.7% |
| 30 | $9.48 | 100 | $948 | 0.1% |
| Total | $9.33 avg | 98,254 | $917K | 100% |
| Filing → |
| ALTH | BUY | 2008-05-30 | $19.7M | — | Filing → |
| ZGEN | BUY | 2008-03-11 | $489K | — | Filing → |
| ZGEN | BUY | 2008-03-05 | $1.3M | — | Filing → |